Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
RaySearch Laboratories AB ( ($SE:RAY.B) ) has provided an announcement.
RaySearch Laboratories has marked a significant milestone in Eastern Europe as the first patient in Ukraine was treated using its RayStation treatment planning system at the Poltava Regional Cancer Clinic. The clinic, a major oncology center in central Ukraine, is the first in the country to deploy RayStation clinically on a conventional linear accelerator, with routine treatments expected to follow and additional Ukrainian clinics set to come online.
The deployment is part of a broader initiative in which RaySearch has donated 20 RayStation systems to ten cancer centers across Ukraine, as well as to Taras Shevchenko National University of Kyiv for training future oncology professionals. Supported by the international nonprofit Help Ukraine Group, the program is modernizing radiotherapy capacity during wartime, enhancing access to precise cancer treatment and strengthening the country’s long-term clinical and educational oncology infrastructure.
The most recent analyst rating on ($SE:RAY.B) stock is a Buy with a SEK210.00 price target. To see the full list of analyst forecasts on RaySearch Laboratories AB stock, see the SE:RAY.B Stock Forecast page.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a Sweden-based medical technology company that develops advanced software solutions for cancer care, including the RayStation radiotherapy treatment planning system and the RayCare oncology information system. Its portfolio also includes the RayIntelligence analytics platform and RayCommand treatment control system, with software installed at more than 1,200 clinics in 51 countries and shares listed on Nasdaq Stockholm since 2003.
Founded in 2000 as a spin-off from the Karolinska Institute in Stockholm, RaySearch focuses on improving the precision and efficiency of radiotherapy and oncology workflows worldwide. The company targets cancer centers and hospitals globally, positioning itself as a key provider of integrated oncology IT and treatment planning infrastructure.
Average Trading Volume: 176,071
Technical Sentiment Signal: Hold
Current Market Cap: SEK6.48B
Learn more about RAY.B stock on TipRanks’ Stock Analysis page.